INCA-ONE CORPORATION – Trademark Portfolio

Entity Type: 03

INCA-ONE CORPORATION has 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 1 (Chemicals). This trademark owner is based in CULVER CITY, CA.

9014 LINDBLADE ST.

CULVER CITY, CA 90230

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INCA-ONE CORPORATION's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

4
Lubricants & Fuels (1 filing)

Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions

Frequently Asked Questions

How many trademarks does INCA-ONE CORPORATION have?

INCA-ONE CORPORATION has 7 U.S. trademarks filed with the USPTO.

What trademark classes does INCA-ONE CORPORATION file in?

INCA-ONE CORPORATION files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 11 (Environmental Control), Class 4 (Lubricants & Fuels). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is INCA-ONE CORPORATION's trademark registration success rate?

INCA-ONE CORPORATION has a 0% trademark registration rate, with 0 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.